United States Non-Small Cell Lung Cancer (NSCLC) Industry 2020 – Pipeline, Epidemiology, Key Products, Market Valuations & Forecast, Drugs Sales and Market Shares – GlobeNewswire

United States Non-Small Cell Lung Cancer (NSCLC) Industry 2020 – Pipeline, Epidemiology, Key Products, Market Valuations & Forecast, Drugs Sales and Market Shares – GlobeNewswire

Dublin, Sept. 04, 2020 (GLOBE NEWSWIRE) — The “US Non-Small Cell Lung Cancer Market and Competitive Landscape – 2020” report has been added to ResearchAndMarkets.com’s offering.

The report provides comprehensive insights into Non-Small Cell Lung Cancer pipeline products, Non-Small Cell Lung Cancer epidemiology, Non-Small Cell Lung Cancer market valuations and forecast, Non-Small Cell Lung Cancer drugs sales and competitive landscape in the US.

The research is classified into seven sections – Non-Small Cell Lung Cancer treatment options, pipeline products, market analysis comprising of epidemiology, key products marketed, market valuations and forecast, drugs sales and market shares.

Research Scope

  • Non-Small Cell Lung Cancer pipeline: Find out the products in clinical trials for the treatment of Non-Small Cell Lung Cancer by development phase 3, phase 2, and phase 1, by pharmacological class and companies developing the products
  • Non-Small Cell Lung Cancer epidemiology: Find out the number of patients diagnosed (prevalence) with Non-Small Cell Lung Cancer in the US
  • Non-Small Cell Lung Cancer drugs: Identify key products marketed and prescribed for Non-Small Cell Lung Cancer in the US, including trade name, molecule name, and company
  • Non-Small Cell Lung Cancer drugs sales: Find out the sales revenues of Non-Small Cell Lung Cancer drugs in the US
  • Non-Small Cell Lung Cancer market valuations: Find out the market size for Non-Small Cell Lung Cancer drugs in 2019 in the US. Find out how the market advanced from 2016 and forecast to 2025
  • Non-Small Cell Lung Cancer drugs market share: Find out the market shares for key Non-Small Cell Lung Cancer drugs in the US

Benefits of this Research

  • Support monitoring and reporting national Non-Small Cell Lung Cancer market analysis and sales trends
  • Track competitor drugs sales and market share in the US Non-Small Cell Lung Cancer market
  • Track competitive developments in Non-Small Cell Lung Cancer market and present key issues and learnings
  • Synthesize insights for Non-Small Cell Lung Cancer market and products to drive business performance
  • Answer key business questions about the Non-Small Cell Lung Cancer market
  • Evaluate commercial market opportunity assessment, positioning, and segmentation for Non-Small Cell Lung Cancer products
  • Supports decision making in R&D to long term marketing strategies

Key Topics Covered
1) Non-Small Cell Lung Cancer Treatments
2) Non-Small Cell Lung Cancer Pipeline
3) US Non-Small Cell Lung Cancer Epidemiology
4) Marketed Drugs for Non-Small Cell Lung Cancer in US
5) US Non-Small Cell Lung Cancer Market Size and Forecast
6) US Non-Small Cell Lung Cancer Products Sales and Forecast
7) US Non-Small Cell Lung Cancer Market Competitive Landscape
8) Methodology

List of Tables
1. Non-Small Cell Lung Cancer Phase 3 Clinical Trials, 2019
2. Non-Small Cell Lung Cancer Phase 2 Clinical Trials, 2019
3. Non-Small Cell Lung Cancer Phase 1 Clinical Trials, 2019
4. Non-Small Cell Lung Cancer Epidemiology, US, 2016-2025
5. Marketed Drugs for Non-Small Cell Lung Cancer, US, 2018
6. Non-Small Cell Lung Cancer Market Size and Forecast ($), US, 2016-2025
7. Non-Small Cell Lung Cancer Product Sales ($), US, 2016-2025

List of Figures
1. Non-Small Cell Lung Cancer Epidemiology, US, 2016-2025
2. Non-Small Cell Lung Cancer Market Size and Forecast ($), US, 2016-2025
3. Non-Small Cell Lung Cancer Products Market Share (%), US, 2018

For more information about this report visit https://www.researchandmarkets.com/r/ramopc

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

CONTACT: ResearchAndMarkets.com
Laura Wood, Senior Press Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Tags:

Share this post

Post Comment